Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from STE

STERIS Stock: Analyst Estimates & Ratings

STERIS has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

3 Specialty Healthcare Providers Addressing Niche Markets

3 Specialty Healthcare Providers Addressing Niche Markets

The healthcare industry is poised for growth driven by the rapid adoption of new and advanced medical technologies to enhance diagnosis. Hence, investors might consider investing in healthcare stocks, such as Agilent Technologies (A), BioNTech (BNTX), and STERIS (STE), which address niche markets. Read more….

Here's What to Expect from STERIS’ Next Earnings Report

Here's What to Expect from STERIS’ Next Earnings Report

Healthcare major STERIS is expected to announce its third-quarter earnings in the upcoming month and analysts expect a modest single-digit growth in earnings.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Is STERIS Stock Underperforming the Nasdaq?

STERIS stock has significantly underperformed the Nasdaq over the past 52 weeks, yet analysts remain strongly bullish on the stock’s prospects.

3 Healthcare Technology Companies Revolutionizing Patient Care

The healthcare technology market is well-poised for long-term growth, thanks to the growing demand for medical devices, cutting-edge technologies, and changing patient care systems. Thus, it could be wise to buy fundamentally solid healthcare technology stocks Zimmer Biomet Holdings (ZBH), STERIS (STE), and Tactile Systems Technology (TCMD), which are revolutionizing…

Do Wall Street Analysts Like STERIS Stock?

Despite STERIS’ underperformance relative to the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Earnings Preview: What to Expect From STERIS' Report

STERIS will release its second-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is STERIS Stock Underperforming the S&P 500?

Is STERIS Stock Underperforming the S&P 500?

STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.

3 MedTech Stocks Revolutionizing Healthcare

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

3 Healthcare Innovators Transforming Patient Care

3 Healthcare Innovators Transforming Patient Care

The healthcare industry's long-term growth is fueled by rising R&D initiatives and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid medical device stocks Alcon (ALC), Becton, Dickinson and Company (BDX), and STERIS (STE) for potential returns. Keep reading.

STERIS Stock Outlook: Is Wall Street Bullish or Bearish?

STERIS Stock Outlook: Is Wall Street Bullish or Bearish?

STERIS has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s potential.

STERIS’ Quarterly Earnings Preview: What You Need to Know

STERIS’ Quarterly Earnings Preview: What You Need to Know

STERIS will unveil its Q1 earnings next month, and analysts project a single-digit bottom-line growth.

3 Medical Equipment Stocks to Buy for a Healthy Portfolio

3 Medical Equipment Stocks to Buy for a Healthy Portfolio

Increased chronic diseases, rising health awareness, and technological developments are poised to keep the medical equipment industry buoyed for the long term. Therefore, medical equipment stocks STERIS plc (STE), Embecta Corp. (EMBC), and Avanos Medical (AVNS), with noteworthy fundamentals, could be solid buys for a healthy portfolio. Read on….

10 Biggest Price Target Changes For Thursday

10 Biggest Price Target Changes For Thursday

Macquarie boosted the price target on Twilio Inc. (NYSE: TWLO) from $281 to $306. Twilio shares jumped 20.4% to $243.23 in pre-market trading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Steris Q3 Sales Jump 50% To $1.2B, Revises FY22 Guidance

Steris plc (NYSE: STE)

Organisations

Agilent Technologies Inc

Medical Devices Equipment

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

252,574 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play